Cost Savings for Prescription Drugs Announced by US HHS
Tuesday, 1 October 2024, 11:51
Cost Savings for Prescription Drugs by US HHS
The US Department of Health and Human Services (HHS) revealed significant cost savings for 54 prescription drugs covered under Medicare Part B. This initiative will go into effect starting in October 2024 and is a crucial part of the Inflation Reduction Act's rebate program aimed at reducing the escalating costs of prescription medications.
Details of the Announcement
- The announcement centers on lowered out-of-pocket costs for patients.
- Novartis' cancer drug is part of this significant list, highlighting the impact on essential treatment accessibility.
- Ozempic, a widely used medication for diabetes, could also be included in future savings initiatives.
These updates represent a pivotal step in addressing the rising costs in healthcare, making vital medications more affordable for Americans.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.